Drug
Brivaracetam clinical trials
Also written Briviact and UCB34714.
- studies test it
- 48
- open now
- 3
- in phase 3
- 26
- first study started
- 2002
Keep track of what changes. Save the brivaracetam studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
48 studies that test it; most in 2021 (5)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 4 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 11
- Phase 2
- 10
- Phase 3
- 26
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
- Epilepsy
- 26
Who runs them
Industry 42 · Other 6
UCB Pharma (16) · UCB Biopharma SRL (10) · UCB Pharma SA (7) · UCB Biopharma S.P.R.L. (3) · University of Minnesota (2) · UCB BIOSCIENCES, Inc. (2) · Jiangxi Qingfeng Pharmaceutical Co. Ltd. (1) · Muhammad Aamir Latif (1)
Often tested with
Tested in the same studies.
Levetiracetam (3) · BRV 25 (1) · BRV 50 (1)
Studies
Open first, then newest update. How each study uses brivaracetam is read from its arms, and is right about nine times in ten.
Testing it · 48
- A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With SeizuresRecruitingPhase 3UCB Biopharma SRLNCT04715646Written as Brivaracetam
- Epileptic Hippocampus in Alzheimer's DiseaseNot yet recruitingPhase 1/2University of California, Los AngelesNCT05899764Written as Brivaracetam
- Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal ConditionsEnrolling by invitationPhase 1Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.NCT06762743Written as Brivaracetam Oral Solution (Test Formulation)
- A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence EpilepsyActive, not recruitingPhase 3UCB Biopharma SRLNCT06315322Written as Brivaracetam Film-coated tablet
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence EpilepsyCompletedPhase 3UCB Biopharma SRLNCT04666610Written as Brivaracetam
- Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse GliomasTerminatedEarly Phase 1University of RochesterNCT05029960Written as Brivaracetam
- Long-term Safety and Efficacy of Adjunctive Brivaracetam in Chinese Patients With Uncontrolled Focal EpilepsyCompletedPhase 3Jiangxi Qingfeng Pharmaceutical Co. Ltd.NCT07563634Written as Brivaracetam
- Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialCompletedPhase 3University of MinnesotaNCT05639946Written as brivaracetam
- A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence EpilepsyCompletedPhase 3UCB Biopharma SRLNCT05109234Written as Brivaracetam Film-coated tablet
- Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With EpilepsyCompletedPhase 3UCB Pharma SANCT01364597Written as Brivaracetam (BRV)
- A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With EpilepsyCompletedPhase 3UCB Biopharma SRLNCT03083665Written as Brivaracetam
- Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord InjuryCompletedPhase 1/2University of MinnesotaNCT04379011Written as Brivaracetam
- Comparison of Intravenous Brivaracetam Versus Levetiracetam in the Management of Status EpilepticusCompletedNot applicableMuhammad Aamir LatifNCT07163572Written as Intravenous brivaracetam
- Comparison of Oral Brivaracetam Versus Levetiracetam as Monotherapy in EpilepsyCompletedNot applicableRESnTEC, Institute of ResearchNCT07163585Written as Brivaracetam
- A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary GeneralizationCompletedPhase 3UCB Biopharma SRLNCT03250377Written as Brivaracetam
- A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Japanese Male Study ParticipantsCompletedPhase 1UCB Biopharma SRLNCT06312566Written as brivaracetam (BRV) tablet
- A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic SeizuresTerminatedPhase 3UCB Biopharma SRLNCT03325439Written as Brivaracetam (BRV) intravenous (iv)
- A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Male Japanese Study ParticipantsCompletedPhase 1UCB Biopharma SRLNCT05315947Written as brivaracetam
- Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and AdultsCompletedPhase 3UCB PharmaNCT00368251Written as BRV 2.5 mg
- A Study to Evaluate the Pharmacokinetics and Safety of Brivaracetam in Healthy Chinese SubjectsCompletedPhase 1UCB Biopharma SRLNCT04882540Written as brivaracetam
See all 48 studies that test brivaracetam →
Given in every arm · 1 — brivaracetam is usual care beside what is tested
As the comparator · 1 — what is tested is compared with brivaracetam
Codes
What other systems call brivaracetam · ClinicalTrials.gg INT004618
- MeSH (NLM) C482793brivaracetamConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) U863JGG2IABRIVARACETAMConfirmed FDA, NLM, Wikidata
- RxNorm 1739745Confirmed FDA, Wikidata
- Wikidata Q408099brivaracetamConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65270BrivaracetamOne source FDA
- DrugBank DB05541One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C482793 | brivaracetam | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | U863JGG2IA | BRIVARACETAM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1739745 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408099 | brivaracetam | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65270 | Brivaracetam | One source FDA |
| DrugBank | DB05541 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.